Application for quotation of securities - NUZ

Aug 25, 2026 at 9:49 PM EDT · Issued by Neurizon Therapeutics Limited via ASX

Filed with ASX · Aug 25, 2026 at 9:49 PM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-nuz-1

Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 6 Announcement Summary Entity name NEURIZON THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Wednesday August 26, 2026 The +securities to be...

View Attachment

6ix hasn’t read this filing yet.

Neurizon Therapeutics Limited on 6ix

Earlier from Neurizon Therapeutics

Appendix 4E and 2026 Annual ReportAug 25
Appendix 4G and Corporate Governance StatementAug 25
Notification regarding unquoted securities - NUZAug 24
Elanco representative appointed as Neurizon Board ObserverAug 12
Neurizon Completes Initial Drawdown under R&D FacilityAug 10

Later from Neurizon Therapeutics

Neurizon Appoints Chief Executive OfficerSep 6
NIH funds Expanded Access Program for NUZ-001 in ALSSep 8
Neurizon Announces Partial Redemption of Convertible NotesSep 9
Notification of cessation of securities - NUZSep 15
Change of Director's Interest NoticeSep 16

All Neurizon Therapeutics news releases

Follow Neurizon Therapeutics into a list and get an email when it puts out news.

Follow Neurizon Therapeutics